Table 2 Clinicopathological characteristics of patient samples and expression of PTOV1 in breast cancer and correlation between PTOV1 expression and clinicopathological characteristics of breast cancer patients
Characteristics | Total | PTOV1 | chi-square test P-value | Fisher’s exact test P-value | ||
|---|---|---|---|---|---|---|
Low expression (%) | High expression (%) | |||||
Age (y) | ≥ 47 | 82 | 43 (52.4) | 39 (47.6) | 0.695 | 0.406 |
< 47 | 87 | 43 (49.4) | 44 (50.6) | |||
Clinical stage | I | 30 | 20 (66.7) | 10 (33.3) | 0.005 | 0.003 |
II | 81 | 46 (56.8) | 35 (43.2) | |||
III | 53 | 20 (37.7) | 33 (62.3) | |||
IV | 5 | 0 (0) | 5 (100) | |||
T classification | T1 | 52 | 31 (59.6) | 21 (40.4) | 0.048 | 0.046 |
T2 | 88 | 46 (52.3) | 42 (47.7) | |||
T3 | 17 | 7 (41.2) | 10 (58.8) | |||
T4 | 12 | 2 (16.7) | 10 (83.3) | |||
N classification | N0 | 72 | 45 (62.5) | 27 (37.5) | 0.035 | 0.036 |
N1 | 50 | 24 (48) | 26 (52) | |||
N2 | 30 | 12 (40) | 18 (60) | |||
N3 | 17 | 5 (29.4) | 12 (70.6) | |||
M classification | Yes | 5 | 0 (0.0) | 5 (100.0) | 0.021 | 0.027 |
No | 164 | 86 (52.4) | 78 (47.6) | |||
Expression of ER | 0 | 74 | 45 (60.8) | 29 (39.2) | 0.003 | 0.003 |
1 | 37 | 23 (62.2) | 14 (37.8) | |||
2 | 16 | 5 (31.3) | 11 (68.5) | |||
3 | 42 | 13 (31.0) | 29 (69.0) | |||
Expression of PR | 0 | 75 | 42 (56.0) | 33 (44.0) | 0.092 | 0.093 |
1 | 28 | 15 (53.6) | 13 (46.4) | |||
2 | 27 | 16 (59.3) | 11 (40.7) | |||
3 | 39 | 13 (33.3) | 26 (66.7) | |||
Expression of HER 2 | 0 | 90 | 42 (46.7) | 48 (53.3) | 0.588 | 0.599 |
1 | 20 | 12 (60.0) | 8 (40.0) | |||
2 | 13 | 8 (61.5) | 5 (38.5) | |||
3 | 46 | 24 (62.5) | 22 (37.5) | |||
Vital status | Live | 131 | 78 (59.5) | 53 (40.5) | < 0.001 | < 0.001 |
Dead | 38 | 8 (21.1) | 30 (78.9) | |||